HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nonsteroidal anti-inflammatory drug sulindac sulfide suppresses structural protein Nesprin-2 expression in colorectal cancer cells.

AbstractBACKGROUND:
Nonsteroidal anti-inflammatory drugs (NSAIDs) are well known for treating inflammatory disease and have been reported to have anti-tumorigenic effects. Their mechanisms are not fully understood, but both cyclooxygenase (COX) dependent and independent pathways are involved. Our goal was to shed further light on COX-independent activity.
METHODS:
Human colorectal cancer cells were observed under differential interference contrast microscopy (DICM), fluorescent microscopy, and micro-impedance measurement. Microarray analysis was performed using HCT-116 cells treated with sulindac sulfide (SS). PCR and Western blots were performed to confirm the microarray data and immunohistochemistry was performed to screen for Nesprin-2 expression. Micro-impedance was repeating including Nesprin-2 knock-down by siRNA.
RESULTS:
HCT-116 cells treated with SS showed dramatic morphological changes under DICM and fluorescent microscopy, as well as weakened cellular adhesion as measured by micro-impedance. Nesprin-2 was selected from two independent microarrays, based on its novelty in relation to cancer and its role in cell organization. SS diminished Nesprin-2 mRNA expression as assessed by reverse transcriptase and real time PCR. Various other NSAIDs were also tested and demonstrated that inhibition of Nesprin-2 mRNA was not unique to SS. Additionally, immunohistochemistry showed higher levels of Nesprin-2 in many tumors in comparison with normal tissues. Further micro-impedance experiments on cells with reduced Nesprin-2 expression showed a proportional loss of cellular adhesion.
CONCLUSIONS:
Nesprin-2 is down-regulated by NSAIDs and highly expressed in many cancers.
GENERAL SIGNIFICANCE:
Our data suggest that Nesprin-2 may be a potential novel oncogene in human cancer cells and NSAIDs could decrease its expression.
AuthorsJason L Liggett, Chang Kyoung Choi, Robert L Donnell, Kenneth D Kihm, Jong-Sik Kim, Kyung-Won Min, Angelika Anna Noegel, Seung Joon Baek
JournalBiochimica et biophysica acta (Biochim Biophys Acta) Vol. 1840 Issue 1 Pg. 322-31 (Jan 2014) ISSN: 0006-3002 [Print] Netherlands
PMID24080406 (Publication Type: Journal Article)
Copyright© 2013.
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Biomarkers, Tumor
  • Microfilament Proteins
  • Nerve Tissue Proteins
  • Nuclear Proteins
  • RNA, Messenger
  • RNA, Small Interfering
  • SYNE2 protein, human
  • Sulindac
  • sulindac sulfide
Topics
  • Anti-Inflammatory Agents, Non-Steroidal (pharmacology)
  • Biomarkers, Tumor (genetics, metabolism)
  • Blotting, Western
  • Cell Adhesion (drug effects)
  • Cell Proliferation (drug effects)
  • Colorectal Neoplasms (drug therapy, metabolism, pathology)
  • Electric Impedance
  • Female
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Humans
  • Immunoenzyme Techniques
  • Male
  • Microfilament Proteins (antagonists & inhibitors, genetics, metabolism)
  • Nerve Tissue Proteins (antagonists & inhibitors, genetics, metabolism)
  • Nuclear Proteins (antagonists & inhibitors, genetics, metabolism)
  • Oligonucleotide Array Sequence Analysis
  • RNA Stability (drug effects)
  • RNA, Messenger (genetics)
  • RNA, Small Interfering (genetics)
  • Real-Time Polymerase Chain Reaction
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sulindac (analogs & derivatives, pharmacology)
  • Tissue Array Analysis
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: